In this study, we investigated the association between systemic inflammation and focal infiltration of inflammatory cells (including intratumoral CD4+, CD8+, CD16+, and CD68+ cells, and CD16/CD8 ratio) and the recurrence of HCC and clinical outcomes. Here, CD68 is linked to hepatocellular carcinoma.